This is the second of three features in the limbic reporting on the ADVENT Advances in Type 2 Inflammatory Diseases medical education series by Sanofi Genzyme. The first ADVENT tutorial reported here focused on the importance of identifying patients with type 2 inflammatory asthma, the second tutorial focuses on the clinical management of two patients ...
Managing severe uncontrolled asthma – cases and approaches
20 Oct 2020
Sponsored by Sanofi-aventis Australia Pty ltd